Search research articles
Contact Us
Filters
Showing results (21-30 of 204) with videos related to
Page
of 21
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
March 5, 2013
Drug concentration monitoring in Mycobacterium avium lung disease: problems with methods and conclusions
Jotam G Pasipanodya, Tawanda Gumbo
The Lancet. Child & Adolescent Health
|
July 21, 2019
Dosing tuberculosis drugs in young children: the road ahead
Jotam G Pasipanodya, Tawanda Gumbo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 8, 2018
Individualizing Tuberculosis (TB) Treatment: Are TB Programs in High Burden Settings Ready for Prime Time Therapeutic Drug Monitoring?
Jotam G Pasipanodya, Tawanda Gumbo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 29, 2020
The Relationship Between Drug Concentration in Tuberculosis Lesions, Epithelial Lining Fluid, and Clinical Outcomes
Jotam G Pasipanodya, Tawanda Gumbo
Current Opinion in Pharmacology
|
August 3, 2011
A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs
Jotam G Pasipanodya, Tawanda Gumbo
The Journal of Antimicrobial Chemotherapy
|
February 5, 2020
Repurposing drugs for treatment of Mycobacterium abscessus: a view to a kill
Tawanda Gumbo, Kayle Cirrincione, Shashikant Srivastava
The Journal of Antimicrobial Chemotherapy
|
September 20, 2017
A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting
Devyani Deshpande, Shashikant Srivastava, Tawanda Gumbo
Frontiers in Pharmacology
|
November 28, 2025
Tigecycline pharmacodynamics in the hollow fiber system of <i>Mycobacterium avium</i>-complex lung disease and the utility of MICs and time-kill studies in drug development
Devyani Deshpande, Shashikant Srivastava, Tawanda Gumbo
Frontiers in Pharmacology
|
November 8, 2021
Repurposing Cefazolin-Avibactam for the Treatment of Drug Resistant <i>Mycobacterium tuberculosis</i>
Shashikant Srivastava, Tawanda Gumbo, Tania Thomas
International Journal of Antimicrobial Agents
|
May 16, 2024
Ertapenem's therapeutic potential for Mycobacterium avium lung disease in the hollow fibre model
Devyani Deshpande, Shashikant Srivastava, Tawanda Gumbo
Page
of 21
Search research articles
Search
Showing results (21-30 of 204) with videos related to
Sort By:
Page
of 21
American Journal of Respiratory and Critical Care Medicine
|
March 5, 2013
Drug concentration monitoring in Mycobacterium avium lung disease: problems with methods and conclusions
Jotam G Pasipanodya, Tawanda Gumbo
The Lancet. Child & Adolescent Health
|
July 21, 2019
Dosing tuberculosis drugs in young children: the road ahead
Jotam G Pasipanodya, Tawanda Gumbo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 8, 2018
Individualizing Tuberculosis (TB) Treatment: Are TB Programs in High Burden Settings Ready for Prime Time Therapeutic Drug Monitoring?
Jotam G Pasipanodya, Tawanda Gumbo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 29, 2020
The Relationship Between Drug Concentration in Tuberculosis Lesions, Epithelial Lining Fluid, and Clinical Outcomes
Jotam G Pasipanodya, Tawanda Gumbo
Current Opinion in Pharmacology
|
August 3, 2011
A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs
Jotam G Pasipanodya, Tawanda Gumbo
The Journal of Antimicrobial Chemotherapy
|
February 5, 2020
Repurposing drugs for treatment of Mycobacterium abscessus: a view to a kill
Tawanda Gumbo, Kayle Cirrincione, Shashikant Srivastava
The Journal of Antimicrobial Chemotherapy
|
September 20, 2017
A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting
Devyani Deshpande, Shashikant Srivastava, Tawanda Gumbo
Frontiers in Pharmacology
|
November 28, 2025
Tigecycline pharmacodynamics in the hollow fiber system of <i>Mycobacterium avium</i>-complex lung disease and the utility of MICs and time-kill studies in drug development
Devyani Deshpande, Shashikant Srivastava, Tawanda Gumbo
Frontiers in Pharmacology
|
November 8, 2021
Repurposing Cefazolin-Avibactam for the Treatment of Drug Resistant <i>Mycobacterium tuberculosis</i>
Shashikant Srivastava, Tawanda Gumbo, Tania Thomas
International Journal of Antimicrobial Agents
|
May 16, 2024
Ertapenem's therapeutic potential for Mycobacterium avium lung disease in the hollow fibre model
Devyani Deshpande, Shashikant Srivastava, Tawanda Gumbo
Page
of 21